A reevaluation of the risk for venous thromboembolism with the use of oral contraceptives and hormone replacement therapy.
- 28 July 1997
- journal article
- review article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 157 (14) , 1522-1530
- https://doi.org/10.1001/archinte.1997.00440350022002
Abstract
There are many health benefits associated with the use or oral contraceptives (OCs) and hormone replacement therapy (HRT), but these agents are also associated with potential health risks.This publication has 3 references indexed in Scilit:
- Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic diseaseThe Lancet, 1995
- Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control studyThe Lancet, 1995
- Optimum duration of anticoagulation for deep-vein thrombosis and pulmonary embolismThe Lancet, 1992